Paolo Tarantino, MD, is a medical oncologist and clinical researcher based in Boston, Massachusetts. He serves as an advanced research fellow at Dana-Farber Cancer Institute and Harvard Medical School, and is affiliated with the European Institute of Oncology and the University of Milan. His work centers on breast cancer, including the biology of HER2 and HER2-low tumors, and the development of novel antibody-drug conjugates. He has presented research at major oncology meetings such as SABCS and ASCO, and has discussed studies from Dana-Farber, including work related to trastuzumab deruxtecan in metastatic breast cancer.
Advanced Research Fellow, Breast Oncology Program
Medical School
Residency
Fellowship